Chris Franck met Dean Follmann during a visit to the Biostatistics Research Branch of the National Institute of Allergy and Infectious Diseases. He grew curious to learn more about Dean, who leads the group, and conducted this featured interview about his work.
covid-19 vaccine
Julia O’Neill Chosen for Q&P Achievement Award
Julia O’Neill contributed to speeding up global regulatory agencies’ early approval of Moderna’s COVID vaccine, SPIKEVAX, for release to the world.
Remembering the Past as We Define the Future
Sastry Pantula suggests taking a moment to reflect on your challenges, resilience, network of friends, and support system during the past 15 months.
A Story of COVID-19, Mentoring, and West Virginia
Learn about how data scientists have helped with different aspects of the COVID-19 response in West Virginia and how one key mentor played a role in this.
Using Our Superpowers to Contribute to the Public Good
Rob Santos believes statisticians are superheroes, but their superpowers are only as good as their underlying assumptions.
Data for Good Can Drive COVID Vaccine Confidence
David Corliss says statisticians can help address the distrust of vaccines, a large challenge of this phase of the COVID-19 pandemic.
Biopharmaceutical Report Focuses on Statistical Issues in COVID-19 Trials
The editorial team invited authors from government, industry, and academia to write articles about their perspectives on the impact of COVID-19 on clinical trials, particularly the statistical issues involved in designing new COVID-19 trials.